Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), the etiological agent of COVID-19, has caused over 460 million cases of infection and over 6 million deaths worldwide. The pandemic has called for science, technology, and innovation to provide solutions and, due to an incredible...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanna, Giuseppina, Marongiu, Alessandra, Firinu, Davide, Piras, Cristina, Franci, Gianluigi, Galdiero, Massimiliano, Pala, Giuseppe, Palmas, Vanessa, Angius, Fabrizio, Littera, Roberto, Perra, Andrea, Orrù, Germano, Campagna, Marcello, Costanzo, Giulia, Meloni, Federico, Coghe, Ferdinando, Chessa, Luchino, Manzin, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024419/
https://www.ncbi.nlm.nih.gov/pubmed/35455280
http://dx.doi.org/10.3390/vaccines10040531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024419/
https://www.ncbi.nlm.nih.gov/pubmed/35455280
http://dx.doi.org/10.3390/vaccines10040531

Ejemplares similares